Cargando…
Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China
Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) during treatment. The different prevalence and distribution patterns of G6PDd in...
Autores principales: | Zeng, Wen, Liu, Ning, Li, Yuchun, Gao, Ai, Yuan, Mengyi, Ma, Rui, Jiang, Na, Sun, Dingwei, Wang, Guangze, Feng, Xinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634581/ https://www.ncbi.nlm.nih.gov/pubmed/36339224 http://dx.doi.org/10.3389/fpubh.2022.1010172 |
Ejemplares similares
-
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries
por: Recht, Judith, et al.
Publicado: (2018) -
Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan
por: Ali Albsheer, Musab M., et al.
Publicado: (2021) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023) -
Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response
por: Mekonnen, Daniel Abebe, et al.
Publicado: (2023) -
Surveillance and Control of Malaria Vectors in Hainan Province, China from 1950 to 2021: A Retrospective Review
por: Sun, Dingwei, et al.
Publicado: (2023)